H.R.4439 - Creating Hope Reauthorization Act116th Congress (2019-2020)
|Sponsor:||Rep. Butterfield, G. K. [D-NC-1] (Introduced 09/20/2019)|
|Committees:||House - Energy and Commerce|
|Committee Reports:||H. Rept. 116-551|
|Latest Action:||Senate - 09/30/2020 Received in the Senate. (All Actions)|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
Text: H.R.4439 — 116th Congress (2019-2020)All Information (Except Text)
Text available as:
Received in Senate (09/30/2020)
To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
This Act may be cited as the “Creating Hope Reauthorization Act”.
Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)(5)) is amended—
(1) by striking “December 11, 2020” each place it appears and inserting “September 30, 2024”; and
(2) in subparagraph (B), by striking “December 11, 2022” and inserting “September 30, 2026”.
Passed the House of Representatives September 29, 2020.
|Attest:||cheryl l. johnson,|